27 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33622325 | Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells. | 2021 Feb 23 | 1 |
2 | 34128573 | ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis. | 2021 Sep | 2 |
3 | 30872116 | Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. | 2019 Aug | 1 |
4 | 28987803 | Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation. | 2018 Feb | 1 |
5 | 29115880 | Treatment response heterogeneity in asthma: the role of genetic variation. | 2018 Jan | 1 |
6 | 29650006 | Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. | 2018 Apr 12 | 1 |
7 | 29653961 | Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists. | 2018 Jul | 1 |
8 | 29992699 | Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. | 2018 Nov | 1 |
9 | 30311516 | Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. | 2018 Oct | 1 |
10 | 27050801 | Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma. | 2016 Oct | 2 |
11 | 27452453 | Triple inhaled therapy for chronic obstructive pulmonary disease. | 2016 Nov | 1 |
12 | 27582089 | Vilanterol and fluticasone furoate for asthma. | 2016 Sep 1 | 1 |
13 | 25377687 | New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives. | 2015 May | 1 |
14 | 26676161 | Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol. | 2015 | 1 |
15 | 24621682 | Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. | 2014 Mar | 3 |
16 | 24641588 | Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management. | 2014 Jul | 1 |
17 | 24279851 | Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort. | 2013 Dec | 2 |
18 | 22526864 | β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients. | 2012 Aug | 2 |
19 | 19430548 | Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment. | 2009 Apr 30 | 2 |
20 | 17901197 | Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. | 2008 Jan | 1 |
21 | 18023995 | Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. | 2008 Feb | 1 |
22 | 18071293 | A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. | 2008 Mar | 1 |
23 | 18666664 | [Practice guideline 'Medical treatment of COPD']. | 2008 Jun 28 | 1 |
24 | 16872239 | Long-acting beta2-agonists in asthma: not so SMART? | 2006 | 1 |
25 | 14668964 | Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype. | 2004 Jan | 1 |
26 | 14524296 | [How to obtain complete control of asthma?]. | 2003 Jun | 2 |
27 | 14651722 | Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. | 2003 Nov | 1 |